Iksung Cho

VP, Biostatistics at Novavax

Mr. Cho is vice president of biostatistics with responsibility for coordinating statistical activities for vaccine candidates in various stages of clinical development. Mr. Cho has 28 years of experience in the biopharmaceutical industry in multiple therapeutic areas. Mr. Cho joined Novavax in December 2015 as executive director of biostatistics. Prior to joining Novavax, he was senior statistician at PATH, an international nonprofit organization that aims to accelerate innovation across vaccines, drugs, diagnostics, devices, and system and service innovations. Mr. Cho’s experience includes positions of increasing responsibility in biostatistics and data management at Merck, Aviron, and MedImmune (AstraZeneca), where he was vice president of global biostatistics. Mr. Cho received his bachelor of science degree in mathematics and computer science from Averett College. He received his master of science degrees in statistics and applied mathematics from Virginia Polytechnic and State University.
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.